Table 2. Individual patients characteristics.
| Patient ID | Age | Sex | Primary Cancer | Histology | Molecular aberration | Previous treatment lines | Smoke habit | Number of tissue/effusions collections |
|---|---|---|---|---|---|---|---|---|
| NP001 | 72 | F | LC | SCLC | No | 1 | PS | 1 |
| PM002 | 49 | M | CRC | ADC | KRAS mut | 3 | NV | 1 |
| SN003 | 69 | F | LC | ADC | No | 3 | NV | 1 |
| LG004 | 54 | M | LC | SqC | No | 2 | PS | 1 |
| ZL005 | 45 | F | LC | ADC | EGFR mut | 3 | NS | 2 |
| GD006 | 42 | M | LC | ADC | EGFR mut | 7 | PS | 1 |
| RG007 | 71 | M | LC | ADC | No | 4 | CS | 1 |
| TR008 | 70 | F | LC | ADC | No | 4 | NS | 1 |
| CM009 | 48 | F | LC | ADC | ALK transl | 1 | NS | 1 |
| GA010 | 66 | M | LC | NAS | No | 0 | PS | 1 |
| CN011 | 56 | M | CRC | ADC | KRAS mut | 4 | PS | 1 |
| BU012 | 80 | M | LC | ADC | No | 1 | NS | 1 |
| BG013 | 71 | M | GI | ADC | NE | 0 | PS | 1 |
| RR014 | 73 | M | GI | ADC | NE | 1 | PS | 1 |
| CM015 | 74 | M | LC | ADC | EGFR mut | 2 | PS | 1 |
| LC016 | 56 | M | LC | ADC | No | 2 | PS | 1 |
| RE017 | 73 | F | CRC | ADC | NE | 1 | NS | 1 |
| SL018 | 50 | F | LC | ADC | No | 3 | NS | 1 |
| PD019 | 52 | M | LC | ADC | KRAS mut | 0 | PS | 1 |
| CV020 | 49 | M | LC | SqC | NE | 2 | PS | 1 |
| ME021 | 85 | F | LC | ADC | No | 1 | NS | 1 |
| CR022 | 55 | M | LC | SqC | NE | 6 | PS | 1 |
| SF023 | 67 | F | LC | ADC | EGFR mut | 3 | NS | 1 |
Abbreviations: F, female; M, male; LC, lung cancer; CRC, colorectal cancer; GI; other gastrointestinal cancer; SCLC, small cell lung cancer; ADC, adenocarcinoma; SqC, squamous cell carcinoma; PS, previous smoker; NV, never smoker; CR, current smoker; NE, not evaluated.